In Brief: Knoll Mavik
Executive Summary
Knoll Mavik: ACE inhibitor trandolapril gains new indication for use in stable patients who have evidence of left-ventricular systolic dysfunction or who are symptomatic from congestive heart failure within the first few days after sustaining acute myocardial infarction. The recommended starting dose for the indication is 1 mg once daily, with titration to a target dose of 4 mg once daily...